Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00926029 · ClinicalTrials.gov registry record · Phase 3
Compare the Clinical Efficacy of Prototype Toothpastes
A Phase 3 study, sponsored by Colgate Palmolive.
- Completed
- Registry status
- Phase 3
- Development phase
- 98
- Enrollment target
NCT00926029: Completed Phase 3 study, sponsored by Colgate Palmolive.
NCT00926029 is a Phase 3 study that has completed, run by Colgate Palmolive. The registered enrollment target is 98 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (87% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00926029, a Phase 3 study, has completed, sponsored by Colgate Palmolive.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 98 participants
- Enrollment target
Study Summary
Clinical study to compare the clinical efficacy of toothpastes on dental plaque and gingival inflammation.
Primary Outcome
Plaque Index score scale 0 to 5 (0 = no plaque, 1 = separate flecks of plaque on the tooth, 2 = a thin continuous band of plaque,3 = a band of plaque up to one-third of the tooth, 4 = plaque covering up to two thirds of the of the tooth, 5 = plaque covering two-thirds or more of the crown of the tooth)
Interventions
- DRUG Fluoride
- DRUG Triclosan, fluoride
- OTHER Metal salt
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 98 participants |
| Start Date | 2008-01 |
| Est. Completion | 2008-04 |
| Phase | Phase 3 |
What the finished NCT00926029 record still lists
NCT00926029 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 98 participants, a relatively small participant target, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (87% lower).
The record links to 0 conditions, and to 3 interventions - of which Fluoride is the first listed.
NCT00926029 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00926029 about?
NCT00926029 is a clinical study titled "Compare the Clinical Efficacy of Prototype Toothpastes". Clinical study to compare the clinical efficacy of toothpastes on dental plaque and gingival inflammation.
What is the current status of trial NCT00926029?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 98 participants. The study started on 2008-01. Estimated completion is 2008-04.
What interventions are being tested in trial NCT00926029?
The interventions under investigation include: Fluoride (DRUG), Triclosan, fluoride (DRUG), Metal salt (OTHER).
Who is sponsoring clinical trial NCT00926029?
This trial is sponsored by Colgate Palmolive, which has 51 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00926029's enrollment target sits among peer trials
98 1714th of 2000 higher than 283 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02926729 · 98 participants · NA
Real-Time Assessment Of Breast Cancer Lumpectomy Specimen Margins With Nonlinear Microscopy
- NCT03382977 · 98 participants · Phase 1
Study to Evaluate Safety, Tolerability, and Optimal Dose of Candidate GBM Vaccine VBI-1901 in Recurrent GBM Subjects
- NCT04577014 · 98 participants · Phase 1
Retifanlimab (Anti-PD-1 Antibody) With Gemcitabine and Docetaxel in Patients With Advanced Soft Tissue Sarcoma
- NCT04817618 · 98 participants · Phase 3
Study of Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia